Home LiteratureArticle Details
PMID: 26462125 Published · ppublish English Journal Article Comment

Kidney cancer: CheckMate for advanced-stage ccRCC? Nivolumab and cabozantinib aMETEORate poor survival.

Nature reviews. Clinical oncology ·Vol. 12 ·No. 11 ·2015-11-00 ·Pages 621

Thoma C

Abstract

暂无摘要

MeSH Terms
Anilides/therapeutic use Antibodies, Monoclonal/therapeutic use Antineoplastic Agents/therapeutic use Carcinoma, Renal Cell/drug therapy Female Humans Kidney Neoplasms/drug therapy Male Pyridines/therapeutic use Sirolimus/analogs & derivatives
Chemicals
Anilides Antibodies, Monoclonal Antineoplastic Agents Pyridines Sirolimus
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Thoma Clemens
Article Info
Journal
Nature reviews. Clinical oncology
Abbr.
Nat Rev Clin Oncol
ISSN
1759-4782
DOI
10.1038/nrclinonc.2015.178
Published
2015-11-00
Epub
2015-00-13
Pages
621
Language
English
Region
England
NLM ID
101500077
Subset
IM
Corrections
CommentOn
PMID: 26406148
CommentOn
PMID: 26406150
ErratumIn
PMID: 26552959
External Links
PubMed source DOI: 10.1038/nrclinonc.2015.178 View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2